> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Radiopharmaceuticals from Outsourcing Facilities
- URL: https://www.fdaweb.com/guide-on-radiopharmaceuticals-from-outsourcing-facilities/
- Published: 2018-09-27T12:00:00.000Z
- Updated: 2026-09-15T00:34:37.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142461

*Federal Register* notice: FDA has made available a final guidance entitled “Compounding and Repackaging of Radiopharmaceuticals by Outsourcing Facilities.” The document describes how FDA intends to apply section 503B of the federal Food, Drug, and Cosmetic Act to radiopharmaceuticals compounded by outsourcing facilities, and it describes the conditions where the agency generally does not intend to take action for violations of certain provisions when an outsourcing facility repackages radiopharmaceuticals. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-09-26/pdf/2018-20901.pdf?ref=fdaweb.com).